Daniel Wintner Goodman serves as Executive at Tonix Pharmaceuticals Holding Corp., where they oversee executive responsibilities. Since joining the company, Daniel Wintner Goodman has executed 1 insider transactions totaling $5.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 25, 2021 involved purchasing 5,000 shares valued at $5.6K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| May 25, 2021 | TNXP | $5.6K | Purchase | 5,000 | $1.12 | Discretionary |
Daniel Wintner Goodman currently holds 5,001 shares of Tonix Pharmaceuticals Holding Corp. (TNXP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel Wintner Goodman has been a net buyer of TNXP stock. They have purchased $5.6K and sold $0 worth of shares.
Daniel Wintner Goodman's most recent insider trade was on May 25, 2021, when they purchased 5,000 shares at $1.12 per share.
Get notified when new Form 4 filings are submitted